Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Patients with short CA segments had a higher frequency of rash (61 %) versus those with long CA repeats (17 %) when treated with gefitinib (p = 0.06).”